Superpower partners with GRAIL to offer multi-cancer blood test
Go back to Superpower partners with GRAIL to offer multi-cancer blood test| (NASDAQ: GRAL) | Delayed: 60.16 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.16 | 52 Week High | $ | |||
| Open | $60.16 | 52 Week Low | $ | |||
| Day High | $60.16 | P/E | N/A | |||
| Day Low | $60.16 | EPS | $ | |||
| Volume | 27 | |||||

